Athira Pharma, Inc. (ATHA) has 47 open-market insider trades by 14 insiders since 2020. The most active filer is Kevin Church, CHIEF SCIENTIFIC OFFICER.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Joseph Edelman | Dir10% Owner | — | 4 | $42.3M | 2023-12-29 |
| RTW Investments, L.P. | 10% Owner | — | 1 | $12.8M | 2020-09-18 |
| Kelly A. Romano | Dir | — | 3 | $304K | 2024-06-24 |
| Andrew Gengos | CFO and Chief Business Officer | — | 5 | $221K | 2024-09-05 |
| Glenna Mileson | CFO | — | 2 | $150K | 2022-12-28 |
| Mark James Litton | Pres | — | 6 | $77K | 2026-01-02 |
| Grant Pickering | Dir | — | 1 | $60K | 2023-03-30 |
| Hans Moebius | Chief Medical Officer | — | 2 | $45K | 2024-01-04 |
| Kevin Church | CHIEF SCIENTIFIC OFFICER | — | 7 | $36K | 2026-01-02 |
| Mark Worthington | CLOCCO | — | 6 | $29K | 2026-01-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Renninger | CFO | Sell | $2K | 2026-01-02 |
| Mark Worthington | CLO & CCO | Sell | $6K | 2026-01-02 |
| Mark James Litton | President | Sell | $18K | 2026-01-02 |
| Martin Javier San | — | Sell | $11K | 2026-01-02 |
| Mark Worthington | General Counsel and CCO | Sell | $2K | 2025-07-01 |
| Robert Renninger | SVP & Finance and Accounting | Sell | $840 |
Companies that share insiders with ATHA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-07-01 |
| Mark James Litton | President | Sell | $7K | 2025-07-01 |
| Martin Javier San | CHIEF MEDICAL OFFICER | Sell | $3K | 2025-07-01 |
| Kevin Church | CHIEF SCIENTIFIC OFFICER | Sell | $5K | 2025-01-02 |
| Martin Javier San | CHIEF MEDICAL OFFICER | Sell | $6K | 2025-01-02 |
| Robert Renninger | VP of Finance | Sell | $2K | 2025-01-02 |
| Mark James Litton | President | Sell | $14K | 2025-01-02 |
| Mark James Litton | President | Sell | $3K | 2024-09-05 |
| Mark Worthington | GENERAL COUNSEL | Sell | $1K | 2024-09-05 |
| Andrew Gengos | CFO and Chief Business Officer | Sell | $725 | 2024-09-05 |